A carregar...
Combining Immune Checkpoint and VEGFR Inhibition in Favorable-risk and Elderly Patients with Metastatic Renal Cell Carcinoma
BACKGROUND: Immune checkpoint inhibitors and VEGFR TKIs are the most commonly used medications in metastatic renal cell carcinoma. Recently, large clinical trials have shown favorable outcomes in patients treated with combined immune checkpoint plus VEGFR inhibition compared to VEGFR inhibition alon...
Na minha lista:
| Publicado no: | Clin Genitourin Cancer |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7875559/ https://ncbi.nlm.nih.gov/pubmed/32144046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2019.11.016 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|